The miRNA-212/132 family regulates both cardiac hypertrophy and cardiomyocyte autophagy
Open accessThe DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Abstract
Pathological growth of cardiomyocytes (hypertrophy) is a major determinant for the development of heart failure, one of the leading medical causes of mortality worldwide. Here we show that the microRNA (miRNA)-212/132 family regulates cardiac hypertrophy and autophagy in cardiomyocytes. Hypertrophic stimuli upregulate cardiomyocyte expression of miR-212 and miR-132, which are both necessary and sufficient to drive the hypertrophic growth of cardiomyocytes. MiR-212/132 null mice are protected from pressure-overload-induced heart failure, whereas cardiomyocyte-specific overexpression of the miR-212/132 family leads to pathological cardiac hypertrophy, heart failure and death in mice. Both miR-212 and miR-132 directly target the anti-hypertrophic and pro-autophagic FoxO3 transcription factor and overexpression of these miRNAs leads to hyperactivation of pro-hypertrophic calcineurin/NFAT signalling and an impaired autophagic response upon starvation. Pharmacological inhibition of miR-132 by antagomir injection rescues cardiac hypertrophy and heart failure in mice, offering a possible therapeutic approach for cardiac failure. Heart failure is often a consequence of pathological growth of cardiomyocytes or cardiac hypertrophy. Here Ucar and colleagues report that the microRNAs miR-132 and miR-212 promote cardiac hypertrophy and inhibit autophagy in cardiomyocytes by downregulating the transcription factor FoxO3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Figures







Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Recently, fine-tuning of FOXO3 levels has been achieved via a miRNA-132 antagonistic approach,157 that is currently clinically tested (NCT04045405).”
From Senescence-induced inflammation: an important player and key therapeutic target in atherosclerosis (2020) · cites this paper as [157]
In the citing paper
“| Cardiomyopathies | Cardiomyocyte‐specific overexpression of miR‐212/132 | Pathological cardiac hypertrophy, heart failure, and premature death, after impaired autophagic response upon starvation | Ucar et al (2012) |”
From Autophagy in major human diseases (2021) · cites this paper as Ucar et al (2012)
In the citing paper
“Along similar lines, the cardiomyocyte‐specific overexpression of miRNAs invalidating the transcriptional activity of FOXO3 (Ucar et al, 2012) or activating MTORC1 (Li et al, 2017) precipitates cardiac function, leading to heart failure.”
From Autophagy in major human diseases (2021) · cites this paper as Ucar et al, 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
1 retracted
Rockman, H. A., Ross, R. S., Harris, A. N., Knowlton, K. U., Steinhelper, M. E., Field, L. J., Ross, J., & Chien, K. R. (1991) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.88.18.8277 · Cited by 797
RetractedMicroRNAs: Target Recognition and Regulatory Functions
Bartel, D. P. (2009) · Cell · doi:10.1016/j.cell.2009.01.002 · Cited by 20,068
Silencing of microRNAs in vivo with ‘antagomirs’
Krützfeldt, J., Rajewsky, N., Braich, R., Rajeev, K. G., Tuschl, T., Manoharan, M., & Stoffel, M. (2005) · Nature · doi:10.1038/nature04303 · Cited by 3,949
Sandri, M., Sandri, C., Gilbert, A., Skurk, C., Calabria, E., Picard, A., Walsh, K., Schiaffino, S., Lecker, S. H., & Goldberg, A. L. (2004) · Cell · doi:10.1016/s0092-8674(04)00400-3 · Cited by 3,012
MicroRNA-21 contributes to myocardial disease by stimulating MAP kinase signalling in fibroblasts
Thum, T., Gross, C., Fiedler, J., Fischer, T., Kissler, S., Bussen, M., Galuppo, P., Just, S., Rottbauer, W., Frantz, S., et al. (2008) · Nature · doi:10.1038/nature07511 · Cited by 2,349
Self-citationHomeostatic levels of p62 control cytoplasmic inclusion body formation in autophagy-deficient mice.
Komatsu, M., Waguri, S., Koike, M., Sou, Y.-S., Ueno, T., Hara, T., Mizushima, N., Iwata, J.-I., Ezaki, J., Murata, S., et al. (2007) · Cell · doi:10.1016/j.cell.2007.10.035 · Cited by 2,124
Jung, C. H., Ro, S.-H., Cao, J., Otto, N. M., & Kim, D.-H. (2010) · FEBS Letters · doi:10.1016/j.febslet.2010.01.017 · Cited by 2,090
Control of translation and mRNA degradation by miRNAs and siRNAs: Table 1.
Valencia-Sanchez, M. A., Liu, J., Hannon, G. J., & Parker, R. (2006) · Genes & Development · doi:10.1101/gad.1399806 · Cited by 2,060
Control of Stress-Dependent Cardiac Growth and Gene Expression by a MicroRNA
van Rooij, E., Sutherland, L. B., Qi, X., Richardson, J. A., Hill, J., & Olson, E. N. (2007) · Science · doi:10.1126/science.1139089 · Cited by 1,657
Ventura, A., Young, A. G., Winslow, M. M., Lintault, L., Meissner, A., Erkeland, S. J., Newman, J., Bronson, R. T., Crowley, D., Stone, J. R., et al. (2008) · Cell · doi:10.1016/j.cell.2008.02.019 · Cited by 1,590
Cited by
Items 101–200 of 609
The role of autophagy in cardiac hypertrophy
Li, L., Xu, J., He, L., Peng, L., Zhong, Q., Chen, L., & Jiang, Z. (2016) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gmw025 · Cited by 85
“However, the overexpression of miR-212/132 promotes pathological cardiac hypertrophy by inhibiting cardiac autophagy [72].”
BackgroundMasson, S., Bátkai, S., Beermann, J., Bär, C., Pfanne, A., Thum, S., Magnoli, M., Balconi, G., Nicolosi, G. L., Tavazzi, L., et al. (2017) · European Journal of Heart Failure · doi:10.1002/ejhf.961 · Cited by 84
Self-citationRawat, D. K., Alzoubi, A., Gupte, R. S., Chettimada, S., Watanabe, M., Kahn, A. G., Okada, T., McMurtry, I. F., & Gupte, S. A. (2014) · Hypertension · doi:10.1161/hypertensionaha.114.03261 · Cited by 83
“In the heart, autophagy contributes to the pathogenesis of both hypertrophy and failure.(35) Recent studies found that autophagy induced by mitochondrial Nox-4–derived ROS and mitochondrial dysfunction causes remodeling of the RV and LV in pulmonary artery banding(52) and in transverse aortic Figure 5.”
BackgroundNew and revisited approaches to preserving the reperfused myocardium
Kloner, R. A., Brown, D. A., CSETE, M. E., Dai, W., Downey, J. M., Gottlieb, R. A., Hale, S. L., & Shi, J. (2017) · Nature Reviews Cardiology · doi:10.1038/nrcardio.2017.102 · Cited by 86
AntimiR-132 Attenuates Myocardial Hypertrophy in an Animal Model of Percutaneous Aortic Constriction
Hinkel, R., Bátkai, S., Bähr, A., Bozoglu, T. M., Straub, S., Borchert, T., Viereck, J., Howe, A., Hornaschewitz, N., Oberberger, L., et al. (2021) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2021.04.028 · Cited by 86
Self-citationMiRNA-181a regulates Toll-like receptor agonist-induced inflammatory response in human fibroblasts
Galicia, J. C., Naqvi, A. R., Ko, C.-C., Nares, S., & khan, A. W. A. (2014) · Genes and Immunity · doi:10.1038/gene.2014.24 · Cited by 84
Hanieh, H. (2015) · Molecular Cancer · doi:10.1186/s12943-015-0443-9 · Cited by 84
“For example, miR-212/132 cluster is involved in mammary gland development [9, 10], neuronal differentiation and cognitive processes [11–13], cardiac hypertrophy and cardiomyocyte autophagy [14], autoimmune inflammation [15], vasodilatory function and angiogenic responses [16].”
BackgroundWu, R., Hu, X., & Wang, J. (2018) · Stem Cells · doi:10.1002/stem.2778 · Cited by 89
Bauersachs, J. K., Solomon, S. D., Anker, S. D., Antorrena, I., Bátkai, S., Viereck, J., Rump, S., Filippatos, G. S., Granzer, U., Ponikowski, P. P., et al. (2024) · European Journal of Heart Failure · doi:10.1002/ejhf.3139 · Cited by 91
Self-citationA Cardiac-enriched MicroRNA, miR-378, Blocks Cardiac Hypertrophy by Targeting Ras Signaling
Nagalingam, R. S., Sundaresan, N. R., Gupta, M. P., Geenen, D. L., Solaro, R. J., & Gupta, M. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.442384 · Cited by 89
RetractedFOXOs in the impaired heart: New therapeutic targets for cardiac diseases
Xin, Z., Ma, Z., Jiang, S., Wang, D., Fan, C., Di, S., Hu, W., Li, T. X., She, J., & Yang, Y. (2016) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2016.11.023 · Cited by 86
Huang, J., Sun, W., Huang, H., Ye, J., Pan, W., Zhong, Y., Cheng, C., You, X., Liu, B., Xiong, L., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094382 · Cited by 80
“Moreover, miR-212 and miR-132 [45] were able to regulate autophagy in cardiomyocytes via their commonly targeting gene of Foxo3 expression.”
BackgroundRetractedVascular importance of the miR-212/132 cluster
Kumarswamy, R., Volkmann, I. R., Beermann, J., Napp, L. C., Jabs, O., Bhayadia, R., Melk, A., Uçar, A., Chowdhury, K., Lorenzen, J. M., et al. (2014) · European Heart Journal · doi:10.1093/eurheartj/ehu344 · Cited by 86
Self-citationMicroRNAs in cardiovascular disease
Gurha, P. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000280 · Cited by 85
González, A., Richards, M., de Boer, R. A., Thum, T., Arfsten, H., Hülsmann, M., Falcão‐Pires, I., Díez, J., Foo, R., Chan, M. Y., et al. (2022) · European Journal of Heart Failure · doi:10.1002/ejhf.2493 · Cited by 86
Self-citationMcKinsey, T. A., Foo, R., Anene-Nzelu, C. G., Travers, J. G., Vagnozzi, R. J., Weber, N., & Thum, T. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac142 · Cited by 90
Self-citationAutophagy—from molecular mechanisms to clinical relevance
Lippai, M., & Szatmári, Z. (2016) · Cell Biology and Toxicology · doi:10.1007/s10565-016-9374-5 · Cited by 83
Amanat, M., Nemeth, C. L., Fine, A. S., Leung, D. G., & Fatemi, A. S. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14112389 · Cited by 79
Xiao, J., Bei, Y., Liu, J., Dimitrova‐Shumkovska, J., Kuang, D., Zhou, Q., Li, J., Yang, Y., Xiang, Y., Wang, F., et al. (2015) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.12733 · Cited by 82
“In fact, miR-212 dysregulation has previously been reported in cancers [44–49], angiogenic responses [50], and cardiac hypertrophy [51].”
BackgroundThe role of autophagy in angiotensin II-induced pathological cardiac hypertrophy
Zhou, L., Ma, B., & Han, X. (2016) · Journal of Molecular Endocrinology · doi:10.1530/jme-16-0086 · Cited by 81
Guan, P., Sun, Z., Wang, N., Zhou, J., Luo, L.-F., Zhao, Y., & Ji, E. (2019) · Life Sciences · doi:10.1016/j.lfs.2019.116748 · Cited by 78
Ma, F., Zhang, X., & Yin, K. (2019) · Experimental Neurology · doi:10.1016/j.expneurol.2019.113094 · Cited by 74
“Moreover, miR-212 and miR-132 are highly expressed in the CNS and participate in synaptic plasticity, neurite outgrowth and endothelial vasodilatory function (Ucar et al., 2012; Wanet et al., 2012).”
BackgroundCardiac Hypertrophy: From Pathophysiological Mechanisms to Heart Failure Development
Caturano, A., Vetrano, E., Galiero, R., Salvatore, T., Docimo, G., Epifani, R., Alfano, M., Sardu, C., Marfella, R., Rinaldi, L., et al. (2022) · Reviews in Cardiovascular Medicine · doi:10.31083/j.rcm2305165 · Cited by 92
“ical hypertrophy by FoxO3 expression inhibition and calcineurin/NFAT signalling and autophagy suppression upregulation [125].”
BackgroundRegulatory RNAs and paracrine networks in the heart
Viereck, J., Bang, C., Foinquinos, A., & Thum, T. (2014) · Cardiovascular Research · doi:10.1093/cvr/cvu039 · Cited by 73
“In the last decade, miRNAs have evolved to act as intracellular regulators of gene expression in a variety of cardiovascular disease.(27,28) Since”
BackgroundSelf-citationNon-coding RNAs as therapeutic targets and biomarkers in ischaemic heart disease
Caporali, A., Anwar, M., Devaux, Y., Katare, R., Martelli, F., Srivastava, P. K., Pedrazzini, T., & Emanueli, C. (2024) · Nature Reviews Cardiology · doi:10.1038/s41569-024-01001-5 · Cited by 77
“108). miR-132-3p has emerged as a target for HF because it causes cardiac hypertrophic and a profibrotic response 109,110 and reduces contractility in HF by suppressing expression of sarcoplasmic/endoplasmic reticulum calcium ATPase 2a (SERCA2a) 111 . miR-132 is the first miRNA therapeutic target…”
Targeted delivery of miRNA therapeutics for cardiovascular diseases: opportunities and challenges
Kwekkeboom, R. F. J., Lei, Z., Doevendans, P. A., Musters, R. J. P., & Sluijter, J. P. G. (2014) · Clinical Science · doi:10.1042/cs20140005 · Cited by 81
Song, D. W., Ryu, J. Y., Kim, J. O., Kwon, E. J., & Kim, D. H. (2013) · Biochemical Journal · doi:10.1042/bj20130833 · Cited by 77
Jiang, B., Zhou, X., Yang, T., Wang, L., Feng, L., Wang, Z., Xu, J., Jing, W., Wang, T., Su, H., et al. (2023) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2023.1088575 · Cited by 76
“(14) attached importance to the role of microRNAs in the heart failure-induced autophagy.”
BackgroundNoncoding RNAs in age-related cardiovascular diseases
Jusic, A., Thomas, P. B., Wettinger, S. B., Dogan, S., Farrugia, R., Gaetano, C., Tuna, B. G., Pinet, F., Robinson, E. L., Tual-Chalot, S., et al. (2022) · Ageing Research Reviews · doi:10.1016/j.arr.2022.101610 · Cited by 70
Mayer, S., Gilsbach, R., Preißl, S., Ordonez, E. B. M., Schnick, T., Beetz, N., Lother, A., Rommel, C., Ihle, H., Bugger, H., et al. (2015) · Circulation Research · doi:10.1161/circresaha.115.306721 · Cited by 72
Self-citationGranzyme B Deficiency Protects against Angiotensin II–Induced Cardiac Fibrosis
Shen, Y., Cheng, F., Sharma, M., Merkulova, Y., Raithatha, S. A., Parkinson, L. G., Zhao, H., Westendorf, K., Bohunek, L., Bozin, T., et al. (2015) · American Journal Of Pathology · doi:10.1016/j.ajpath.2015.09.010 · Cited by 83
Long Noncoding RNAs and Cardiac Disease
Greco, S., Salgado‐Somoza, A., Devaux, Y., & Martelli, F. (2017) · Antioxidants and Redox Signaling · doi:10.1089/ars.2017.7126 · Cited by 72
“Worth of note is that Plekhm1 inhibits autophagy (108) and decreased autophagy is linked with cardiac remodeling (139).”
Suppressor of IKKɛ is an essential negative regulator of pathological cardiac hypertrophy
Deng, K., Wang, A., Ji, Y., Zhang, X., Fang, J., Zhang, Y., Zhang, P., Jiang, X., Gao, L., Zhu, X., et al. (2016) · Nature Communications · doi:10.1038/ncomms11432 · Cited by 69
MicroRNAs in urine supernatant as potential non-invasive markers for bladder cancer detection
Pospíšilová, Š., Pazourková, E., Hořínek, A., Brisuda, A., Svobodová, I., Soukup, V., HRBACEK, J., Čapoun, O., Hanuš, T., Mareš, J., et al. (2016) · Neoplasma · doi:10.4149/neo_2016_518 · Cited by 75
“Numerous target genes regulated by miRNAs are known [7-10], however, many regulatory relationships remain undiscovered.”
BackgroundResearch Advances in Heart Failure: A Compendium
Braunwald, E. (2013) · Circulation Research · doi:10.1161/circresaha.113.302254 · Cited by 85
“Overexpression of miR-132 and miR-212 causes HF, and their genetic deletion protects the ventricles from pressure load–induced hypertrophy.(32) MiR378 attenuates such hypertrophy by suppressing the mitogenic-actiaved protein kinase pathway.”
BackgroundRNA Therapeutics for the Cardiovascular System
Dzau, V. J., & Hodgkinson, C. P. (2024) · Circulation · doi:10.1161/circulationaha.123.067373 · Cited by 79
“Zebrafishing” for Novel Genes Relevant to the Glomerular Filtration Barrier
Hanke, N., Staggs, L., Schröder, P., Litteral, J., Fleig, S. V., Kaufeld, J. K., Pauli, C., Haller, H. G., & Schiffer, M. (2013) · BioMed Research International · doi:10.1155/2013/658270 · Cited by 73
“MicroRNAs are highly conserved throughout vertebrates; thus, specific effects of microRNAs identified in mice or human tissues can be tested immediately in the zebrafish system [36].”
BackgroundSelf-citationObesity‐induced mitochondrial dysfunction in porcine adipose tissue‐derived mesenchymal stem cells
Meng, Y., Eirin, A., Zhu, X., Tang, H. R., Chanana, P., Lerman, A., van Wijnen, A. J., & Lerman, L. O. (2017) · Journal of Cellular Physiology · doi:10.1002/jcp.26402 · Cited by 67
“, 2015), whereas miRNA-212 in conjunction with miR-132 regulates cardiac hypertrophy and mitophagy by targeting the pro-autophagic transcription factor FoxO3 (Ucar et al., 2012).”
BackgroundSmall molecules, big effects: the role of microRNAs in regulation of cardiomyocyte death
Skommer, J., Rana, I., Marques, F. Z., Zhu, W., Du, Z., & Charchar, F. J. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.287 · Cited by 67
Xie, M., Fu, Z., Cao, J., Liu, Y., Wu, J., Li, Q., & Chen, Y. (2018) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2018.03.088 · Cited by 69
Bali, P., & Kenny, P. J. (2013) · Frontiers in Genetics · doi:10.3389/fgene.2013.00043 · Cited by 69
“In the other study, Ucar et al. demonstrate that these miRNAs activate calcineurin signaling in cardiomyocytes by targeting the transcription factor Foxo3, and thus play an important role in cardiac hypertrophy (Ucar et al., 2012).”
BackgroundMacrophages dictate the progression and manifestation of hypertensive heart disease
Kain, D., Amit, U., Yagil, C., Landa, N., Naftali‐Shani, N., Molotski, N., Aviv, V., Feinberg, M. S., Goitein, O., Kushnir, T., et al. (2015) · International Journal of Cardiology · doi:10.1016/j.ijcard.2015.10.126 · Cited by 67
MicroRNAs and human diseases: diagnostic and therapeutic potential
Maqbool, R., & Hussain, M. U. (2014) · Cell and Tissue Research · doi:10.1007/s00441-013-1787-3 · Cited by 70
Noncoding RNAs as regulators of cardiomyocyte proliferation and death
Piccoli, M.-T., Gupta, S. K., & Thum, T. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.02.002 · Cited by 65
“Recently, miRNAs were demonstrated to regulate cardiac autophagy in vitro and in vivo [77].”
BackgroundSelf-citationNoncoding RNAs in Cardiac Hypertrophy
Li, Y., Liang, Y., Zhu, Y., Zhang, Y., & Bei, Y. (2018) · Journal of Cardiovascular Translational Research · doi:10.1007/s12265-018-9797-x · Cited by 66
MicroRNAs in Cardiac Autophagy: Small Molecules and Big Role
Sun, T., Li, M., Li, P., & Cao, J.-M. (2018) · Cells · doi:10.3390/cells7080104 · Cited by 63
“The MiR-212/132 null mice do not frequently develop hypertrophy and heart failure, whereas the overexpression of miR-212/132 leads to the hyperactivation of pro-hypertrophic calcineurin/NFAT signaling and an impaired autophagic response in response to starvation [20].”
BackgroundCross talk between miR-214 and PTEN attenuates glomerular hypertrophy under diabetic conditions
Wang, X., Shen, E., Wang, Y., Li, J., Cheng, D., Chen, Y., Gui, D., & Wang, N. (2016) · Scientific Reports · doi:10.1038/srep31506 · Cited by 60
The Role and Molecular Mechanism of Non-Coding RNAs in Pathological Cardiac Remodeling
Gao, J., Xu, W., Wang, J., Wang, K., & Li, P. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18030608 · Cited by 64
Wronska, A. (2022) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.121.001152 · Cited by 60
Fan, X., Cao, J., Li, M., Zhang, D., El‐Battrawy, I., Chen, G., Zhou, X., Yang, G., & Akın, İ. (2024) · Advanced Science · doi:10.1002/advs.202307698 · Cited by 84
MicroRNA-34a Suppresses Autophagy in Tubular Epithelial Cells in Acute Kidney Injury
Liu, X., Hong, Q., Wang, Z., Yu, Y., Zou, X., & Xu, L. (2015) · American Journal of Nephrology · doi:10.1159/000439185 · Cited by 61
Mitochondrial Autophagy: – An Essential Quality Control Mechanism for Myocardial Homeostasis –
Thomas, R. L., & Gustafsson, Å. B. (2013) · Circulation Journal · doi:10.1253/circj.cj-13-0835 · Cited by 58
Plasma miR-22-5p, miR-132-5p, and miR-150-3p Are Associated with Acute Myocardial Infarction
Li, H., Zhang, P., Li, F., Yuan, G., Wang, X., Zhang, A., & Li, F. (2019) · BioMed Research International · doi:10.1155/2019/5012648 · Cited by 67
Varzideh, F., Kansakar, U., Donkor, K., Wilson, S. M., Jankauskas, S. S., Mone, P., Wang, X., Lombardi, A., & Santulli, G. (2022) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2022.863238 · Cited by 58
Next RNA Therapeutics: The Mine of Non-Coding
Garbo, S., Maione, R., Tripodi, M., & Battistelli, C. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23137471 · Cited by 62
Posttranscriptional regulation of FOXO expression: microRNAs and beyond
Urbánek, P., & Klotz, L. (2016) · British Journal of Pharmacology · doi:10.1111/bph.13471 · Cited by 64
“Intriguingly, antagomir injection inmice to blockmiR-132 function prevents cardiac hypertrophy and heart failure (Ucar et al., 2012).”
BackgroundInfluentialHeart failure: Pilot transcriptomic analysis of cardiac tissue by RNA-sequencing
Schiano, C., Costa, V., Aprile, M., Grimaldi, V., Maiello, C., Esposito, R., Soricelli, A., Colantuoni, V., Donatelli, F., Ciccodicola, A., et al. (2017) · Cardiology Journal · doi:10.5603/cj.a2017.0052 · Cited by 61
Xie, S., Deng, Y., Pan, Y., Wang, Z., Ren, J., Guo, X., Yuan, X., Shang, J., & Liu, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.06.149 · Cited by 61
Deciphering Non-coding RNAs in Cardiovascular Health and Disease
Das, A., Samidurai, A., & Salloum, F. N. (2018) · Frontiers in Cardiovascular Medicine · doi:10.3389/fcvm.2018.00073 · Cited by 60
“Moreover, the overexpression of miR-212 and miR-132 directly targets the anti-hypertrophic and pro-autophagic FoxO3 transcription factor and leads to cardiac hypertrophy and HF by inducing pro-hypertrophic calcineurin/NFAT signaling (89).”
BackgroundHamdani, N., Costantino, S., Mügge, A., Lebeche, D., Tschöpe, C., Thum, T., & Paneni, F. (2021) · European Heart Journal · doi:10.1093/eurheartj/ehab197 · Cited by 56
Self-citationProfiling of differentially expressed microRNAs in arrhythmogenic right ventricular cardiomyopathy
Zhang, H., Liu, S., Dong, T., Yang, J., Xie, Y., Wu, Y., Kang, K., Hu, S., Gou, D., & Wei, Y. (2016) · Scientific Reports · doi:10.1038/srep28101 · Cited by 64
“Over expression of miR-212 was sufficient to induce hyper activation of pro-hypertrophic Calcineurin/NFAT signalling and impaired autophagy 49 .”
miR-212/132 Cluster Modulation Prevents Doxorubicin-Mediated Atrophy and Cardiotoxicity
Gupta, S. K., Garg, A., Avramopoulos, P., Engelhardt, S. H., Streckfuß‐Bömeke, K., Bátkai, S., & Thum, T. (2018) · Molecular Therapy · doi:10.1016/j.ymthe.2018.11.004 · Cited by 56
Self-citationBär, C., Chatterjee, S., Falcão‐Pires, I., Gonçalves‐Rodrigues, P., Sluijter, J. P. G., Boon, R. A., Nevado, R. M., Andrés, V., Sansonetti, M., Windt, L. J. D., et al. (2020) · Cardiovascular Research · doi:10.1093/cvr/cvaa195 · Cited by 61
“Importantly, pharmacological blockade of miR-132 to normalize its levels promotes functional recovery and RR in small and large HF animal models.(92,93)”
BackgroundSelf-citationSong, L., Zhou, F., Cheng, L., Hu, M., He, Y., Zhang, B., Liao, D., & Xu, Z. (2017) · Inflammation · doi:10.1007/s10753-017-0537-1 · Cited by 54
“The miR-101 inhibits autophagy in the MCF-7 cell line [6], and the miRNA-212/132 family regulates cardiomyocyte autophagy [21].”
BackgroundAutophagy: Cancer, Other Pathologies, Inflammation, Immunity, Infection, and Aging
(2017) · Elsevier eBooks · doi:10.1016/c2016-0-02189-7 · Cited by 64
Zech, A. T. L., Singh, S. R., Schlossarek, S., & Carrier, L. (2019) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2019.01.013 · Cited by 59
Self-citationPharmacokinetics and Proceedings in Clinical Application of Nucleic Acid Therapeutics
Herkt, M., & Thum, T. (2020) · Molecular Therapy · doi:10.1016/j.ymthe.2020.11.008 · Cited by 56
Self-citationYang, X., Zhang, M., Xie, B., Peng, Z., Manning, J. R., Zimmerman, R., Wang, Q., Wei, A., Khalifa, M., Reynolds, M. J., et al. (2022) · Cardiovascular Research · doi:10.1093/cvr/cvac096 · Cited by 58
The roles of non-coding RNAs in vascular calcification and opportunities as therapeutic targets
Ryu, J., Ahn, Y., Kook, H. Y., & Kim, Y. (2020) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2020.107675 · Cited by 56
Cell type–specific microRNA therapies for myocardial infarction
Liu, B., Wang, B., Zhang, X., Lock, R., Nash, T., & Vunjak-Novakovic, G. (2021) · Science Translational Medicine · doi:10.1126/scitranslmed.abd0914 · Cited by 53
“(60) demonstrated that the miR-212/132 family inhibited autophagy and that their inhibition restored the autophagic response, resulting in the rescue of heart failure in mice.”
BackgroundZhang, W., Liu, Y., Fu, Y., Han, W., Xu, H., Wen, L., Deng, Y., & Liu, K. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.02.014 · Cited by 52
RetractedEpigenetic regulation in heart failure
Kim, S. Y., Morales, C. R., Gillette, T. G., & Hill, J. A. (2016) · Current Opinion in Cardiology · doi:10.1097/hco.0000000000000276 · Cited by 51
Regulation of adrenal and ovarian steroidogenesis by miR-132
Hu, Z., Shen, W., Kraemer, F. B., & Azhar, S. (2017) · Journal of Molecular Endocrinology · doi:10.1530/jme-17-0011 · Cited by 56
“2009) and it (along with family member miR-212) contributes to the pathogenesis of cardiac hypertrophy and cardiomyocyte autophagy (Ucar et al. 2012).”
MicroRNAs: Diagnostic, Prognostic and Therapeutic Role in Heart Failure—a Review
Gargiulo, P., Marzano, F., Salvatore, M., Basile, C., Buonocore, D., Parlati, A. L. M., Nardi, E., Asile, G., Abbate, V., Colella, A., et al. (2022) · ESC Heart Failure · doi:10.1002/ehf2.14153 · Cited by 56
“Preclinical investigations identified miR-132 as a promising target, capable to influence the pathological cardiac remodelling in HF.(55) In accordance, treatment with CDR132L has shown therapeutic efficacy in a pig model of post-ischaemic HF, with improvement of cardiac function and relevant antifibrotic and antihype…”
BackgroundThe role and molecular mechanism of epigenetics in cardiac hypertrophy
Lei, H. C., Hu, J., Sun, K., & Xu, D. (2020) · Heart Failure Reviews · doi:10.1007/s10741-020-09959-3 · Cited by 53
Autophagy in cardiovascular diseases: role of noncoding RNAs
Gao, J., Chen, X., Shan, C., Wang, Y., Li, P., & Shao, K. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.10.039 · Cited by 57
“Similarly, miR-212/132 directly targeted the anti-hypertrophic and pro-autophagic FoxO3 transcription factor to impair autophagic response and activate calcineurin/NFAT signaling, leading to pathological cardiac hypertrophy.(48) In summary, the above miRNAs can inhibit autophagy, and lower levels of autophagy activity…”
BackgroundZhang, Y., Ding, Y., Li, M., Yuan, J., Yu, Y., Bi, X., Hong, H., Ye, J., & Liu, P. (2021) · Acta Pharmaceutica Sinica B · doi:10.1016/j.apsb.2021.09.020 · Cited by 50
Atrial myocyte-derived exosomal microRNA contributes to atrial fibrosis in atrial fibrillation
Hao, H., Yan, S. R., Zhao, X., Han, X., Fang, N., Zhang, Y., Dai, C., Li, W., Yu, H., Gao, Y., et al. (2022) · Journal of Translational Medicine · doi:10.1186/s12967-022-03617-y · Cited by 54
“Several miRNAs play critical roles in hypertrophic and fibrotic myocardial tissues, suggesting an association between specific miRNA levels and the development of pathological cardiac remodeling [36, 37].”
BackgroundSmall Engine, Big Power: MicroRNAs as Regulators of Cardiac Diseases and Regeneration
Joladarashi, D., Thandavarayan, R. A., Babu, S. S., & Krishnamurthy, P. (2014) · International Journal of Molecular Sciences · doi:10.3390/ijms150915891 · Cited by 53
“Clinical and preclinical studies have shown that miRNA-212 is up-regulated during heart failure [45,83,84].”
BackgroundInteractions between microRNAs and long non-coding RNAs in cardiac development and repair
Rotini, A., Martínez‐Sarrà, E., Pozzo, E., & Sampaolesi, M. (2017) · Pharmacological Research · doi:10.1016/j.phrs.2017.05.029 · Cited by 51
miR-27a-5p Attenuates Hypoxia-induced Rat Cardiomyocyte Injury by Inhibiting Atg7
Zhang, J., Qiu, W., Ma, J., Wang, Y., Hu, Z., Long, K., Wang, X., Jin, L. G., Tang, Q., Tang, G., et al. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102418 · Cited by 50
“miRNA-212/132 family induce both cardiac hypertrophy and heart failure by activating pro-hypertrophic calcineurin/NFAT signaling, while inhibiting autophagic response upon starvation by directly targeting the anti-hypertrophic and pro-autophagic FoxO3 transcription factor [8].”
BackgroundZhang, L., Peng, H., Zhang, W., Li, Y., Liu, L., & Leng, T. (2020) · Theranostics · doi:10.7150/thno.46761 · Cited by 50
“Although loss of miRNA functional phenotypes induced by miRNA antagonists have been widely used in many diseases studies [33-35], it is worth further study by increasing the tissue specificity of the drug delivery system.”
BackgroundMethodFunctions of miRNAs during Mammalian Heart Development
Yan, S., & Jiao, K. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17050789 · Cited by 51
“The effectiveness of this approach has been demonstrated in animal models with myocardial hypertrophy, heart failure, and cardiac fibrosis [64,65].”
BackgroundGheinani, A. H., Kiss, B. M., Moltzahn, F., Keller, I., Bruggmann, R., Rehrauer, H., Aquino, C., Burkhard, F. C., & Monastyrskaya, K. (2017) · JCI Insight · doi:10.1172/jci.insight.89560 · Cited by 49
MicroRNAs in the diagnosis and prevention of drug-induced cardiotoxicity
Skála, M., Hanousková, B., Skálová, L., & Matoušková, P. (2018) · Archives of Toxicology · doi:10.1007/s00204-018-2356-z · Cited by 48
“The pharmacological inhibition of miR-132 by antagomiR injection rescues cardiac hypertrophy and heart failure in mice (Ucar et al. 2012).”
BackgroundFiedler, J., Stoehr, A., Gupta, S. K., Hartmann, D., Holzmann, A., Just, A., Hansen, A., Hilfiker‐Kleiner, D., Eschenhagen, T., & Thum, T. (2013) · Antioxidants and Redox Signaling · doi:10.1089/ars.2013.5418 · Cited by 47
“Endogenous small noncoding microRNAs (miRNAs) are powerful posttranscriptional regulator of various physiological and pathological conditions (17, 21, 22, 24).”
Self-citationHirt, M. N., Werner, T., Indenbirken, D., Alawi, M., Demin, P., Kunze, A.-C., Stenzig, J., Starbatty, J., Hansen, A., Fiedler, J., et al. (2015) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.01.008 · Cited by 47
“The regulation of the 6most abundantly expressed and byAE upregulated microRNAs (miR-21-5p, miR-146b-5p, miR-208b-3p, miR-3515p, miR-31-5p, miR-21-3p) and 3 other interesting upregulated microRNAs (miR-210-3p, which was very strongly upregulated; miR140-3p, which has been misclassified in the literature as a minor (“s…”
MethodSelf-citationCounteracting Protein Kinase Activity in the Heart: The Multiple Roles of Protein Phosphatases
Weber, S., Meyer-Roxlau, S., Wagner, M., Dobrev, D., & El‐Armouche, A. (2015) · Frontiers in Pharmacology · doi:10.3389/fphar.2015.00270 · Cited by 56
Hyttinen, J. M. T., Błasiak, J., Felszeghy, S., & Kaarniranta, K. (2021) · Ageing Research Reviews · doi:10.1016/j.arr.2021.101260 · Cited by 50
Adding a “Notch” to Cardiovascular Disease Therapeutics: A MicroRNA-Based Approach
Marracino, L., Fortini, F., Bouhamida, E., Camponogara, F., Severi, P., Mazzoni, E., Patergnani, S., D’Aniello, E., Campana, R., Pinton, P., et al. (2021) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2021.695114 · Cited by 49
Non-coding RNAs as modulators of the cardiac fibroblast phenotype
Piccoli, M.-T., Bär, C., & Thum, T. (2016) · Journal of Molecular and Cellular Cardiology · doi:10.1016/j.yjmcc.2015.12.023 · Cited by 50
Self-citationMicroRNAs regulating superoxide dismutase 2 are new circulating biomarkers of heart failure
Dubois‐Deruy, E., Cuvelliez, M., Fiedler, J., Charrier, H., Mulder, P. G. H., Hebbar, E., Pfanne, A., Beseme, O., Chwastyniak, M., Amouyel, P., et al. (2017) · Scientific Reports · doi:10.1038/s41598-017-15011-6 · Cited by 57
Self-citationZhi, Y., Chen, X., Sui, D., Du, J., Xu, F., & Li, Y. (2019) · Advanced Science · doi:10.1002/advs.201900023 · Cited by 46
Myocardial reverse remodeling: how far can we rewind?
Gonçalves‐Rodrigues, P., Leite-Moreira, A. F., & Falcão‐Pires, I. (2016) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00696.2015 · Cited by 53
The heterocellular heart: identities, interactions, and implications for cardiology
Lother, A., & Köhl, P. (2023) · Basic Research in Cardiology · doi:10.1007/s00395-023-01000-6 · Cited by 52
“Mechanistic studies had shown before that miR-132 is a driver of pathological hypertrophy, expressed in cardio-myocytes but not in fibroblasts [200].”
BackgroundRegulation of cardiac microRNAs induced by aerobic exercise training during heart failure
de Souza, R. W. A., Fernández, G. J., Cunha, J. P. Q. C., Piedade, W. P., Soares, L. C., Castro, P. A. T. D. S., de Campos, D. H. S., Okoshi, K., Cicogna, A. C., Dal‐Pai‐Silva, M., et al. (2015) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00941.2014 · Cited by 51
Wu, H., Wang, Y.-C., Wang, X., Li, R., & Yin, D. (2017) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2017.01.108 · Cited by 48
Hu, Z., Zhang, L., Wang, H., Wang, Y., Tan, Y., Dang, L., Wang, K., Sun, Z., Li, G., Cao, X., et al. (2020) · Stem Cell Research & Therapy · doi:10.1186/s13287-020-1581-6 · Cited by 46
Functional Role of microRNAs in Regulating Cardiomyocyte Death
Kansakar, U., Varzideh, F., Mone, P., Jankauskas, S. S., & Santulli, G. (2022) · Cells · doi:10.3390/cells11060983 · Cited by 50
Zhao, G. (2018) · Journal of Medical Genetics · doi:10.1136/jmedgenet-2018-105387 · Cited by 45
Metadata
- Authors
- Ucar, A., Gupta, S. K., Fiedler, J., Erikci, E., Kardasinski, M., Batkai, S., Dangwal, S., Kumarswamy, R., Bang, C., Holzmann, A., Remke, J., Caprio, M., Jentzsch, C., Engelhardt, S., Geisendorf, S., Glas, C., Hofmann, T. G., Nessling, M., Richter, K., Schiffer, M., Carrier, L., Napp, L. C., Bauersachs, J., Chowdhury, K., & Thum, T.
- Affiliations
- Medizinische Hochschule Hannover (DE)
- IRCCS San Raffaele Roma (IT)
- Technical University of Munich (DE)
- Max Planck Institute for Biophysical Chemistry (DE)
- German Cancer Research Center (DE)
- Mount Desert Island Biological Laboratory (US)
- University Medical Center Hamburg-Eppendorf (DE)
- Corresponding author
- Chowdhury, Kamal
- Thum, Thomas
- ORCID
- Venue
- Nature Communications
- Published
- 2012-09-25
- Volume
- 3
- Issue
- 1
- Pages
- 1078-1078
- ISSN
- 2041-1723 (ISSN-L)
- PMC
- PMC3657998
- OpenAlex
- W2101080348
- Cited by
- 610
- References
- 46
- Citations by year
- 2026: 19 · 2025: 28 · 2024: 47 · 2023: 32 · 2022: 60 · 2021: 53 · 2020: 52 · 2019: 41 · 2018: 43 · 2017: 51 · 2016: 47 · 2015: 67 · 2014: 44 · 2013: 26
- FWCI
- 28.19
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by-nc-sa
- creativecommons.org/licenses/by-nc-sa/3.0/ (tdm)
- creativecommons.org/licenses/by-nc-sa/3.0/ (vor)
- Locations
- Nature Communications (publishedVersion, cc-by-nc-sa)
- Europe PMC (PubMed Central) (publishedVersion, cc-by-nc-sa)
- PubMed Central (publishedVersion, cc-by-nc-sa)
- PubMed (publishedVersion)
- RePEc: Research Papers in Economics (submittedVersion)
- mediaTUM – the media and publications repository of the Technical University Munich (Technical University Munich) (submittedVersion)
- Research Explorer (The University of Manchester) (submittedVersion)
- MPG.PuRe (Max Planck Society) (submittedVersion, other-oa)
- Funders
- Baden-Württemberg Stiftung
- Deutsches Krebsforschungszentrum
- Deutsche Forschungsgemeinschaft (DFG-TH903/10-1, 01EO0802, SCHI587/3)
- Bundesministerium für Bildung und Forschung (01EO0802)
- Max-Planck-Gesellschaft
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Fibrosis and Remodeling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › MicroRNA in disease regulation
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Signaling Pathways in Disease
- Keywords
- miR-212, miR-132, cardiac hypertrophy, cardiomyocyte autophagy, heart failure, FOXO3, pressure overload, antagomir, cardiomyocyte-specific overexpression, starvation-induced autophagy
- MeSH terms
- Antagomirs, Animals, Autophagy, Cells, Cultured, Cardiomegaly, Male, Mice, Transgenic, Oligonucleotides, Calcineurin, Reverse Transcriptase Polymerase Chain Reaction, Myocytes, Cardiac, MicroRNAs, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.